NANOBIOTIX (EPA:NANO) | Finanzwire

Basculer en Français

11006	Companies
241123	Keywords
169702	Articles
129803	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 07/09/2024 at 22:20, 2 years 2 months ago

Voting Rights and Shares Capital of Nanobiotix

Voting Rights Shares Euronext Nasdaq NANOBIOTIX
PRESS RELEASE

published on 07/09/2024 at 22:15, 2 years 2 months ago

Voting Rights and Shares Capital of the Company
Nanobiotix discloses voting rights and shares capital information as per French Commercial Code. Check the latest figures for June 30, 2024

Euronext Paris Voting Rights French Commercial Code Shares Capital NANOBIOTIX
BRIEF

published on 07/03/2024 at 15:54, 2 years 2 months ago

Threshold crossings at NANOBIOTIX by Goldman Sachs Group

AMF Goldman Sachs NANOBIOTIX Threshold Crossings
BRIEF

published on 06/12/2024 at 22:20, 2 years 3 months ago

Nanobiotix hosts virtual discussion on the potential of NBTXR3 in cancer treatments

Immunotherapy Head And Neck Cancer NANOBIOTIX NBTXR3 Virtual Discussion
PRESS RELEASE

published on 06/12/2024 at 22:15, 2 years 3 months ago

NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
Nanobiotix to host virtual KOL event discussing NBTXR3 combined with immunotherapy in head and neck cancer and beyond on June 18, 2024

Immunotherapy Head And Neck Cancer NANOBIOTIX NBTXR3 Virtual KOL Event
BRIEF

published on 06/11/2024 at 22:20, 2 years 3 months ago

Nanobiotix: Monthly Information on Voting Rights and Shares

Voting Rights Euronext Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 06/11/2024 at 22:15, 2 years 3 months ago

Voting Rights and Shares Capital of the Company
Nanobiotix discloses its voting rights and shares capital information as of May 31, 2024, in compliance with regulatory requirements. The company is a clinical biotechnology firm listed on Euronext Paris and Nasdaq

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF

published on 06/02/2024 at 16:05, 2 years 3 months ago

Nanobiotix Announces Promising Data on NBTXR3 for Head and Neck Cancer Patients

Clinical Trial Head And Neck Cancer NANOBIOTIX NBTXR3 ASCO
PRESS RELEASE

published on 06/02/2024 at 16:00, 2 years 3 months ago

Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
Nanobiotix announces new data from Study 1100 showing disease control and tumor response in patients with R/M HNSCC treated with RT-activated NBTXR3 followed by anti-PD-1. Investor event scheduled on June 2nd

NANOBIOTIX Study 1100 R/M HNSCC RT-activated NBTXR3 Anti-PD-1
BRIEF

published on 05/28/2024 at 22:20, 2 years 3 months ago

NANOBIOTIX Presents New Data at ASCO 2024

Immunotherapy NANOBIOTIX NBTXR3 ASCO Phase 1

Accesswire

Published on 09/16/2026 at 23:45, 17 minutes ago

Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 2 hours 32 minutes ago

Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 7 hours 7 minutes ago

CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 9 hours 2 minutes ago

2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 10 hours 2 minutes ago

Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update

View all ACCESSWIRE

EQS Group

Published on 09/16/2026 at 23:45, 17 minutes ago

WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 1 hour 28 minutes ago

EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 2 hours 47 minutes ago

Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 3 hours 34 minutes ago

EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 19:05, 4 hours 57 minutes ago

EcoFlow to showcase its open home energy ecosystem at Solar & Storage Live Zurich 2026

Les Echos

Published on 09/16/2026 at 20:46, 3 hours 16 minutes ago

LNA SANTE : 2026 First Half Results
Published on 09/16/2026 at 17:45, 6 hours 17 minutes ago

5th edition of “On the way up” show
Published on 09/16/2026 at 17:45, 6 hours 17 minutes ago

Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 17 hours 2 minutes ago

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 6 hours ago

Report on the Combined General Meeting of the 10th of September 2026

View all LES ECHOS COMFI WIRE